Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 2
1931 1
1989 1
1991 1
1993 1
1995 3
1996 1
1997 2
1998 3
1999 3
2000 2
2001 5
2002 4
2003 3
2004 5
2005 4
2006 3
2007 1
2008 3
2009 1
2010 4
2011 2
2012 5
2013 7
2014 12
2015 11
2016 9
2017 14
2018 15
2019 9
2020 10
2021 10
2022 12
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Christian-Mathias
Page 1
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.
Gottschlich A, Thomas M, Grünmeier R, Lesch S, Rohrbacher L, Igl V, Briukhovetska D, Benmebarek MR, Vick B, Dede S, Müller K, Xu T, Dhoqina D, Märkl F, Robinson S, Sendelhofert A, Schulz H, Umut Ö, Kavaka V, Tsiverioti CA, Carlini E, Nandi S, Strzalkowski T, Lorenzini T, Stock S, Müller PJ, Dörr J, Seifert M, Cadilha BL, Brabenec R, Röder N, Rataj F, Nüesch M, Modemann F, Wellbrock J, Fiedler W, Kellner C, Beltrán E, Herold T, Paquet D, Jeremias I, von Baumgarten L, Endres S, Subklewe M, Marr C, Kobold S. Gottschlich A, et al. Nat Biotechnol. 2023 Nov;41(11):1618-1632. doi: 10.1038/s41587-023-01684-0. Epub 2023 Mar 13. Nat Biotechnol. 2023. PMID: 36914885 Free PMC article.
Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached.
Wilcock DJ, Badrock AP, Wong CW, Owen R, Guerin M, Southam AD, Johnston H, Telfer BA, Fullwood P, Watson J, Ferguson H, Ferguson J, Lloyd GR, Jankevics A, Dunn WB, Wellbrock C, Lorigan P, Ceol C, Francavilla C, Smith MP, Hurlstone AFL. Wilcock DJ, et al. Cell Rep. 2022 Jun 21;39(12):110995. doi: 10.1016/j.celrep.2022.110995. Cell Rep. 2022. PMID: 35732120 Free PMC article.
TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis.
Brauneck F, Fischer B, Witt M, Muschhammer J, Oelrich J, da Costa Avelar PH, Tsoka S, Bullinger L, Seubert E, Smit DJ, Bokemeyer C, Ackermann C, Wellbrock J, Haag F, Fiedler W. Brauneck F, et al. J Immunother Cancer. 2022 Dec;10(12):e004794. doi: 10.1136/jitc-2022-004794. J Immunother Cancer. 2022. PMID: 36549780 Free PMC article.
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
Redondo-Muñoz M, Rodriguez-Baena FJ, Aldaz P, Caballé-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, Carrasco-Garcia E, Olias-Arjona A, Lasheras-Otero I, Santamaria E, Bocanegra A, Chocarro L, Grier A, Dzieciatkowska M M, Bigas C, Martin J, Urdiroz-Urricelqui U, Marzo F, Santamaria E, Kochan G, Escors D, Larrayoz IM, Heyn H, D'Alessandro A, Attolini CS, Matheu A, Wellbrock C, Benitah SA, Sanchez-Laorden B, Arozarena I. Redondo-Muñoz M, et al. Nat Metab. 2023 Sep;5(9):1544-1562. doi: 10.1038/s42255-023-00861-4. Epub 2023 Aug 10. Nat Metab. 2023. PMID: 37563469 Free PMC article.
Overcoming resistance to BRAF inhibitors.
Arozarena I, Wellbrock C. Arozarena I, et al. Ann Transl Med. 2017 Oct;5(19):387. doi: 10.21037/atm.2017.06.09. Ann Transl Med. 2017. PMID: 29114545 Free PMC article. Review.
Antifibrotic drugs as therapeutic tools in resistant melanoma.
Sanchez-Laorden B, Nieto MA. Sanchez-Laorden B, et al. EMBO Mol Med. 2022 Mar 7;14(3):e15449. doi: 10.15252/emmm.202115449. Epub 2022 Feb 14. EMBO Mol Med. 2022. PMID: 35156326 Free PMC article.
Lineage plasticity has also emerged as an important mechanism of non-genetic adaptive melanoma drug resistance in the clinic (Arozarena & Wellbrock, 2019), highlighting the need for a deeper characterization of the mechanisms that control this process. ...
Lineage plasticity has also emerged as an important mechanism of non-genetic adaptive melanoma drug resistance in the clinic (Arozarena & …
Targeting invasive properties of melanoma cells.
Arozarena I, Wellbrock C. Arozarena I, et al. FEBS J. 2017 Jul;284(14):2148-2162. doi: 10.1111/febs.14040. Epub 2017 Mar 1. FEBS J. 2017. PMID: 28196297 Free article. Review.
Targeting MITF in the tolerance-phase.
Arozarena I, Smith MP, Wellbrock C. Arozarena I, et al. Oncotarget. 2016 Aug 23;7(34):54094-54095. doi: 10.18632/oncotarget.9423. Oncotarget. 2016. PMID: 27528022 Free PMC article. No abstract available.
Melanoma biology and new targeted therapy.
Gray-Schopfer V, Wellbrock C, Marais R. Gray-Schopfer V, et al. Nature. 2007 Feb 22;445(7130):851-7. doi: 10.1038/nature05661. Nature. 2007. PMID: 17314971 Review.
163 results